Sun Pharma gains on US Supreme Court ruling in favour of its arm over patent litigation

18 Apr 2012 Evaluate

Sun Pharmaceutical Industries is currently trading at Rs. 596.90, up by 12.70 points or 2.17% from its previous closing of Rs. 584.20 on the BSE.

The scrip opened at Rs. 590.00 and has touched a high and low of Rs. 600.50 and Rs. 585.25 respectively. So far 43,000 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 1 has touched a 52 week high of Rs. 600.50 on 18-Apr-2012 and a 52 week low of Rs. 423.10 on 23-May-2011.

Last one week high and low of the scrip stood at Rs. 600.50 and Rs. 564.50 respectively. The current market cap of the company is Rs. 61,812.00 crore.

The promoters holding in the company stood at 63.72% while Institutions and Non-Institutions held 25.56% and 10.73% respectively.

The United States Supreme Court has ruled in favour of Sun Pharmaceutical Industries’ subsidiary Caraco Pharmaceutical Laboratories in its patent litigation against Novo-Nordisk over Caraco’s generic version of Prandin, Repaglinide tablets.

The Supreme Court, in a unanimous opinion, concluded that Caraco can seek correction of Novo Nordisk’s inaccurate use code regarding the combination use of repaglinide and metformin for the treatment of type 2 diabetes. This landmark decision will help all generic companies prevent brand companies from improperly delaying or preventing the marketing of generic drugs against their products by misrepresenting their patents to the USFDA.

Caraco’s ANDA for generic Prandin is still awaiting approval at the USFDA. Also, a separate appeal concerning the validity of patents for Prandin is currently pending before the Court of Appeals for the Federal Circuit after a lower court ruled in favour of Caraco. Prandin has annual sales of approximately $1,230 million in the US.

Sun Pharmaceutical Industries is an international, integrated, speciality pharmaceutical company. It manufactures and markets a large basket of pharmaceutical formulations as branded generics as well as generics in India, US and several other markets across the world.

Sun Pharma Inds. Share Price

1804.95 -13.65 (-0.75%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×